BIOCON LIMITED

Biocon Limited Company Introduction

Biocon Limited is primarily a manufacturer. It is a leading Indian biopharmaceutical company that researches, develops, manufactures, and markets novel therapies, biosimilars, and generic formulations. It operates its own manufacturing facilities for its pharmaceutical products.

The company focuses on various therapeutic areas including diabetes, oncology, immunology, and others. Biocon is recognized for its work in producing affordable biosimilars and biopharmaceuticals, making it a significant player in the global healthcare industry. It is headquartered in Bangalore, India, and has a global presence.

Products Manufactured or Sold:

1. Biosimilars

Insulin products: Insulin Glargine, Insulin Aspart, Recombinant Human Insulin

Oncology biosimilars: Trastuzumab, Pegfilgrastim, Bevacizumab

Autoimmune biosimilars: Adalimumab, Etanercept

Nephrology biosimilars: Erythropoietin

2. Branded Formulations

Diabetes: Basalog One, Insugen

Oncology: CANMAb, BIOMAb-EGFR

Immunology and chronic diseases: Various formulations

3. Biopharmaceutical APIs Active Pharmaceutical Ingredients

Statins: Rosuvastatin, Atorvastatin

Immunosuppressants: Tacrolimus, Mycophenolate Mofetil

Other fermentation-derived APIs

4. Novel Biologics

Itolizumab ALZUMAb for psoriasis and certain other indications.